Putting the search for genes in perspective

International Journal of Health Services

Volumn 31, Issue 2, 2001, Pages 445-461

  Holtzman, N A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL FACTOR; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HEREDITY; REVIEW;

ENVIRONMENTAL HEALTH; GENE THERAPY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTH CARE RATIONING; HUMAN GENOME PROJECT; HUMANS; PHARMACOGENETICS; POLITICS; PUBLIC HEALTH; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SOCIAL ENVIRONMENT; UNITED STATES;

EID: 0035008138     PISSN: 00207314     EISSN: None     Source Type: Journal    
DOI: 10.2190/JPFC-A4NW-KWT6-Y2H7     Document Type: Review

References (51)

1. Genetic code of human life is cracked by scientists
2. The gene hunt
3. The new genetics of clinical practice
4. Shattuck lecture - Medical and societal consequences of the Human Genome Project
5. Genetic technologies and achieving health for populations
6. Environmental and heritable factors in the causation of cancer - Analysis of cohorts of twins from Sweden, Denmark, and Finland
7. Genetic causes of hearing loss
8. Dominant modifier DFNM1 suppresses recessive deafness DFNB26
9. Gene therapy of human severe combined immunodeficiency (SCID) disease
10. A population-based study of the clinical expression of the hemochromatosis gene
11. Insights into the functions of BRCA1 and BRCA2
12. Cancer risk associated with germline DNA mismatch repair gene mutations
13. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
14. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
15. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
16. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
17. Will genetics revolutionize medicine?
18. Synergistic heterozygosity: Disease resulting from multiple partial defects in one or more metabolic pathways
19. High risk of cerebral-vein thrombosis in carriers of a prothrombingene mutation and in users of oral contraceptives
20. HIV-1 resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
21. Breast and ovarian cancer risks among women with BRCA1 and BRCA2 mutations in the New York Breast Cancer Study (NYBCS)
22. Molecular epidemiology of lung cancer
23. Is there a genetic basis for lung cancer susceptibility?
24. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons
25. Will genetics revolutionize medicine?
26. Genetic homogeneity of Icelanders: Fact or fiction?
27. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci
28. Genetic modifiers of BRCA1 penetrance
29. The RAD51-135 SNP modifies breast and ovarian cancer risk in BRCA2 carriers, but not in BRCA1 carriers
30. How many diseases does it take to map a gene with SNPs?
31. Full-genome scan for linkage in 50 families segregating the bipolar affective disease phenotype
32. An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk
33. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
34. Single nucleotide polymorphism libraries: Why and how are we building them?
35. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
36. Proteomics: New perspectives, new biomedical opportunities
37. Associations of disease with genetic markers: Deja vu all over again
38. Eugenics and individual phenotypic variation: To what extent is biology a predictive science?
39. Abnormal human hemoglobin. III. The chemical difference between normal and sickle cell hemoglobin
40. Pharmacogenetics and adverse drug reactions
41. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders
42. Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization
43. Psychological responses to genetic testing
44. Traditional epidemiology, modern epidemiology, and public health
45. Modifier genes convert "simple" Mendelian disorders to complex traits
46. A tale of 3 tails
47. New paradigms for quality in primary care